
Jennifer Kolb Michener
Examiner (ID: 14501)
| Most Active Art Unit | 1762 |
| Art Unit(s) | 1776, 1762, 1728, 1721, 1600, 1758 |
| Total Applications | 478 |
| Issued Applications | 245 |
| Pending Applications | 84 |
| Abandoned Applications | 163 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19949456
[patent_doc_number] => 12320816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-03
[patent_title] => Assay device for diagnosis of open-globe ocular injuries
[patent_app_type] => utility
[patent_app_number] => 18/882314
[patent_app_country] => US
[patent_app_date] => 2024-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 16212
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882314
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/882314 | Assay device for diagnosis of open-globe ocular injuries | Sep 10, 2024 | Issued |
Array
(
[id] => 19921730
[patent_doc_number] => 12295989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Controlled-release PTH compound
[patent_app_type] => utility
[patent_app_number] => 18/421786
[patent_app_country] => US
[patent_app_date] => 2024-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28357
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18421786
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/421786 | Controlled-release PTH compound | Jan 23, 2024 | Issued |
Array
(
[id] => 18737962
[patent_doc_number] => 20230346864
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Compositions and Methods for Joint Health
[patent_app_type] => utility
[patent_app_number] => 18/218839
[patent_app_country] => US
[patent_app_date] => 2023-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15023
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18218839
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/218839 | Compositions and Methods for Joint Health | Jul 5, 2023 | Abandoned |
Array
(
[id] => 18757281
[patent_doc_number] => 20230360740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => 3D PHARMACOPHORE MODEL FOR THE RAPID COMPUTATIONAL SCREENING OF SARS-COV-2 MODULATORS AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/212555
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18212555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/212555 | 3D PHARMACOPHORE MODEL FOR THE RAPID COMPUTATIONAL SCREENING OF SARS-COV-2 MODULATORS AND COMPOSITIONS AND METHODS THEREOF | Jun 20, 2023 | Abandoned |
Array
(
[id] => 19049328
[patent_doc_number] => 20240091297
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => METHOD FOR ISOLATION OF MAO INHIBITORS FROM TEQUILA OR OTHER DISTILLED AGAVE FERMENTATION PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/140549
[patent_app_country] => US
[patent_app_date] => 2023-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3653
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18140549
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/140549 | METHOD FOR ISOLATION OF MAO INHIBITORS FROM TEQUILA OR OTHER DISTILLED AGAVE FERMENTATION PRODUCTS | Apr 26, 2023 | Abandoned |
Array
(
[id] => 18536028
[patent_doc_number] => 20230241115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/173177
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173177
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173177 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | Feb 22, 2023 | Abandoned |
Array
(
[id] => 18536027
[patent_doc_number] => 20230241114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
[patent_app_type] => utility
[patent_app_number] => 18/173174
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37638
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173174
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173174 | PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS | Feb 22, 2023 | Abandoned |
Array
(
[id] => 18657704
[patent_doc_number] => 20230303650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-28
[patent_title] => Immunoconjugates of Interlukin-2 Mutant Polypeptides with Antibodies
[patent_app_type] => utility
[patent_app_number] => 18/157264
[patent_app_country] => US
[patent_app_date] => 2023-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18157264
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/157264 | Immunoconjugates of Interlukin-2 Mutant Polypeptides with Antibodies | Jan 19, 2023 | Abandoned |
Array
(
[id] => 19922928
[patent_doc_number] => 12297199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Morphinan derivatives and use thereof
[patent_app_type] => utility
[patent_app_number] => 18/085945
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15737
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18085945
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/085945 | Morphinan derivatives and use thereof | Dec 20, 2022 | Issued |
Array
(
[id] => 18647653
[patent_doc_number] => 20230293423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-21
[patent_title] => ANTIOXIDANT COMPOSITIONS AND METHODS OF PROTECTING SKIN, HAIR AND NAILS AGAINST HIGH ENERGY BLUE-VIOLET LIGHT
[patent_app_type] => utility
[patent_app_number] => 18/083833
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18083833
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/083833 | ANTIOXIDANT COMPOSITIONS AND METHODS OF PROTECTING SKIN, HAIR AND NAILS AGAINST HIGH ENERGY BLUE-VIOLET LIGHT | Dec 18, 2022 | Abandoned |
Array
(
[id] => 18565618
[patent_doc_number] => 20230255945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => FORMULATIONS OF PYRROLOPYRIDINE-ANILINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/992859
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69224
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17992859
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/992859 | Formulations of pyrrolopyridine-aniline compounds | Nov 21, 2022 | Issued |
Array
(
[id] => 19961796
[patent_doc_number] => 12331283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 18/052975
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 1977
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18052975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/052975 | None | Nov 6, 2022 | Issued |
| 17/968886 | METHODS FOR REPLENISHMENT OF ANTIMICROBIAL BIPHASIC POLYMERS | Oct 18, 2022 | Abandoned |
Array
(
[id] => 19111166
[patent_doc_number] => 20240122916
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => Effect of YEL002 on Conditions and Diseases
[patent_app_type] => utility
[patent_app_number] => 18/045152
[patent_app_country] => US
[patent_app_date] => 2022-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18045152
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/045152 | Effect of YEL002 on Conditions and Diseases | Oct 7, 2022 | Abandoned |
Array
(
[id] => 18279318
[patent_doc_number] => 20230094790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/937285
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40631
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937285 | Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers | Sep 29, 2022 | Issued |
Array
(
[id] => 18226326
[patent_doc_number] => 20230065320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PANCREATIC CANCER AND OTHER CANCERS
[patent_app_type] => utility
[patent_app_number] => 17/937165
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40542
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937165 | Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers | Sep 29, 2022 | Issued |
Array
(
[id] => 19921736
[patent_doc_number] => 12295995
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers
[patent_app_type] => utility
[patent_app_number] => 17/937268
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 36083
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17937268
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/937268 | Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers | Sep 29, 2022 | Issued |
Array
(
[id] => 18161538
[patent_doc_number] => 20230028130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => Coronavirus Therapeutics and Treatment Methods
[patent_app_type] => utility
[patent_app_number] => 17/934801
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19529
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934801
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934801 | Coronavirus Therapeutics and Treatment Methods | Sep 22, 2022 | Abandoned |
Array
(
[id] => 18221472
[patent_doc_number] => 20230060466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => MEDICAL DEVICE AND METHOD FOR TREATMENT OF OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 17/899329
[patent_app_country] => US
[patent_app_date] => 2022-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17899329
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/899329 | MEDICAL DEVICE AND METHOD FOR TREATMENT OF OSTEOARTHRITIS | Aug 29, 2022 | Abandoned |
Array
(
[id] => 19923025
[patent_doc_number] => 12297296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-13
[patent_title] => Nano small peptide and its use in preparation of drugs for treating and preventing fundus vascular diseases
[patent_app_type] => utility
[patent_app_number] => 17/898331
[patent_app_country] => US
[patent_app_date] => 2022-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 18
[patent_no_of_words] => 0
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17898331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/898331 | Nano small peptide and its use in preparation of drugs for treating and preventing fundus vascular diseases | Aug 28, 2022 | Issued |